Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Meta-analysis demonstrates association of XRCC1 genetic polymorphism Arg399Gln with esophageal cancer risk in the Chinese population.

Zhang ZY, Xuan Y, Jin XY, Tian X, Wu R.

Genet Mol Res. 2013 Jan 16;12(3):2567-77. doi: 10.4238/2013.January.16.2.

2.

XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis.

Li S, Deng Y, You JP, Chen ZP, Peng QL, Huang XM, Lu QH, Huang XL, Zhao JM, Qin X.

Dig Dis Sci. 2013 Jul;58(7):1880-90. doi: 10.1007/s10620-013-2569-1. Epub 2013 Mar 30.

PMID:
23543084
3.

Haplotype analysis of XRCC1 (at codons 194 and 399) and susceptibility to breast cancer, a meta-analysis of the literatures.

Saadat M.

Breast Cancer Res Treat. 2010 Dec;124(3):785-91. doi: 10.1007/s10549-010-0895-y. Epub 2010 Apr 17.

PMID:
20411322
4.

XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies.

Dai L, Wang K, Zhang J, Lv Q, Wu X, Wang Y.

Int J Cancer. 2009 Sep 1;125(5):1102-9. doi: 10.1002/ijc.24446.

5.

[The association of XRCC2 gene polymorphism with susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in China].

Wang N, Dong XJ, Li Y, Guo W, Zhou RM, Zhang XJ, Wang SJ.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Oct;24(5):538-43. Chinese.

PMID:
17922422
6.

XRCC1 codon 280 and ERCC2 codon 751 polymorphisms and risk of esophageal squamous cell carcinoma in a Chinese population.

Zhai XD, Mo YN, Xue XQ, Zhao GS, Gao LB, Ai HW, Ye Y.

Bull Cancer. 2009 Oct;96(10):E61-5. doi: 10.1684/bdc.2009.0952.

7.

EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians.

Dura P, Bregitha CV, Te Morsche RH, Roelofs HM, Kristinsson JO, Wobbes T, Witteman BJ, Tan AC, Drenth JP, Peters WH.

Oncol Rep. 2012 Jun;27(6):1710-6. doi: 10.3892/or.2012.1734. Epub 2012 Mar 19.

PMID:
22447130
8.

Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.

Saadat M, Ansari-Lari M.

Breast Cancer Res Treat. 2009 May;115(1):137-44. doi: 10.1007/s10549-008-0051-0. Epub 2008 May 15.

PMID:
18481169
9.

Genetic polymorphism of DNA base-excision repair genes (APE1, OGG1 and XRCC1) and their correlation with risk of lung cancer in a Chinese population.

Li Z, Guan W, Li MX, Zhong ZY, Qian CY, Yang XQ, Liao L, Li ZP, Wang D.

Arch Med Res. 2011 Apr;42(3):226-34. doi: 10.1016/j.arcmed.2011.04.005.

PMID:
21722819
10.

Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck.

Li C, Hu Z, Lu J, Liu Z, Wang LE, El-Naggar AK, Sturgis EM, Spitz MR, Wei Q.

Cancer. 2007 Aug 15;110(4):867-75.

11.

XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.

Hu Z, Hu X, Long J, Su L, Wei B.

Gene. 2013 Oct 10;528(2):67-73. doi: 10.1016/j.gene.2013.07.005. Epub 2013 Jul 17.

PMID:
23872202
12.

Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis.

Yang D, Liu C, Shi J, Wang N, Du X, Yin Q, Wang Y.

Gene. 2014 Jan 15;534(1):17-23. doi: 10.1016/j.gene.2013.10.038. Epub 2013 Oct 29.

PMID:
24176953
13.

Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.

Wang B, Wang D, Zhang D, Li A, Liu D, Liu H, Jin H.

Eur J Cancer Prev. 2010 Jul;19(4):299-307. doi: 10.1097/CEJ.0b013e32833964bc.

PMID:
20389250
14.

XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.

Ding DP, Ma WL, He XF, Zhang Y.

Mol Biol Rep. 2012 Mar;39(3):2533-40. doi: 10.1007/s11033-011-1005-x. Epub 2011 Jun 11.

PMID:
21667112
15.

Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.

Ma WQ, Han XQ, Wang X, Wang Y, Zhu Y, Liu NF.

PLoS One. 2016 Nov 21;11(11):e0166961. doi: 10.1371/journal.pone.0166961. eCollection 2016.

16.

Polymorphisms in the DNA repair gene XRCC1 associated with basal cell carcinoma and squamous cell carcinoma of the skin in a Korean population.

Kang SY, Lee KG, Lee W, Shim JY, Ji SI, Chung KW, Chung YK, Kim NK.

Cancer Sci. 2007 May;98(5):716-20. Epub 2007 Mar 9.

17.

Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer.

Ratnasinghe LD, Abnet C, Qiao YL, Modali R, Stolzenberg-Solomon R, Dong ZW, Dawsey SM, Mark SD, Taylor PR.

Cancer Lett. 2004 Dec 28;216(2):157-64.

PMID:
15533591
18.

Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.

Dong LM, Zhang XY, Teng H, Li MS, Wang P.

Genet Mol Res. 2014 Nov 28;13(4):9976-85. doi: 10.4238/2014.November.28.2.

19.

Association of polymorphisms in X-ray repair cross complementing 1 gene and risk of esophageal squamous cell carcinoma in a Chinese population.

Yun YX, Dai LP, Wang P, Wang KJ, Zhang JY, Xie W.

Biomed Res Int. 2015;2015:509215. doi: 10.1155/2015/509215. Epub 2015 Feb 1.

20.

Genetic polymorphisms in the DNA repair gene XRCC1 and susceptibility to glioma in a Han population in northeastern China: a case-control study.

Wang D, Hu Y, Gong H, Li J, Ren Y, Li G, Liu A.

Gene. 2012 Nov 10;509(2):223-7. doi: 10.1016/j.gene.2012.08.023. Epub 2012 Aug 23.

PMID:
22951806

Supplemental Content

Support Center